ALDER BIOPHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
26 Sep 2019	Form 3: H Lundbeck A S, 10% owner Holds 0 shares of Common Stock, par value $0.0001
10 Apr 2019	Form 3: Dac Nadia, Chief Commercial Officer Holds 0 shares of No securities are beneficially owned.
23 Jan 2019	Form 3: Streck Paul, Chief Medical Officer Holds 0 shares of No securities are beneficially owned.
14 Dec 2018	Form 3: Campoy Carlos, Chief Financial Officer Holds 0 shares of No securities are beneficially owned.
15 Jun 2018	Form 3: Azelby Robert, Director Holds 0 shares of No securities are beneficially owned.
26 Apr 2018	Form 3: Redmile Group, Llc, Director and 1 other Holds 6,505,766 shares of Common Stock
25 Apr 2018	Form 3: Carter Eric G, Interim Chief Medical Officer Holds 0 shares of No securities are beneficially owned.
18 Apr 2018	Form 3: Lavelle Erin, Chief Commercial Officer Holds 0 shares of No securities are beneficially owned.
07 Apr 2017	Form 3: Yarno Wendy L, Director Holds 0 shares of No securities are beneficially owned
08 Sep 2016	Form 3: Sandoval Elisabeth, Chief Commercial Officer Holds 0 shares of No securities are beneficially owned.
30 Jun 2016	Form 3: Whitaker Timothy M, Chief Medical Officer Holds 0 shares of No securities are beneficially owned.
28 Jan 2016	Form 3: Bucher James B, Sr. VP & General Counsel Holds 0 shares of No securities are beneficially owned.
30 Sep 2015	Form 3: Carter Paul Rutherford, Director Holds 0 shares of No securities are beneficially owned.
27 Aug 2015	Form 3: Cleveland Paul B, Director Holds 0 shares of No securities are beneficially owned
05 Sep 2014	Form 3: Hassler Randal, SVP, Manufacturing No securities owned
07 May 2014	Form 3: Ventures West 8 Limited Partnership, 10% owner
07 May 2014	Form 3: Siegall Clay B, Director
07 May 2014	Form 3: Montgomery Alan Bruce, Director
07 May 2014	Form 3: Delphi Management Partners VII, L.l.c., 10% owner and 6 others
07 May 2014	Form 3: Pakianathan Deepika, Director

Comments